Blood flow restricted walking in patients suffering from intermittent claudication: a case series feasibility and safety study
- PMID: 37229056
- PMCID: PMC10205295
- DOI: 10.1097/MS9.0000000000000673
Blood flow restricted walking in patients suffering from intermittent claudication: a case series feasibility and safety study
Abstract
To examine the feasibility and safety of blood flow restricted walking (BFR-W) in patients with intermittent claudication (IC). Moreover, to evaluate changes in objective performance-based and self-reported functioning following 12 weeks of BFR-W.
Materials and methods: Sixteen patients with IC were recruited from two departments of vascular surgery. The BFR-W programme implied the application of a pneumatic cuff around the proximal part of the affected limb at 60% limb occlusion pressure in five intervals of 2 min, four times per week for 12 weeks. Feasibility was evaluated by adherence and completion rates of the BFR-W programme. Safety was evaluated by adverse events, ankle-brachial index (ABI) at baseline and follow-up, and pain on a numerical rating scale (NRS pain) before and 2 min after training sessions. Furthermore, changes in performance between baseline and follow-up were evaluated with the 30 seconds sit-to-stand test (30STS), the 6-minute walk test (6MWT) and the IC questionnaire (ICQ).
Results: Fifteen out of 16 patients completed the 12-week BFR-W programme and adherence was 92.8% (95% CI: 83.4; 100%). One adverse event unrelated to the intervention was reported causing one patient to terminate the programme 2 weeks prematurely. Mean NRS pain 2 min following BFR-W was 1.8 (95% CI [1.7-2]). ABI, 30STS, 6MWT and ICQ score were improved at follow-up.
Conclusions: BFR-W is feasible and appears to be safe in terms of completion rate, adherence to the training protocol, and adverse events in patients with IC. Further investigation of the effectiveness and safety of BFR-W compared to regular walking exercise is needed.
Keywords: blood flow restricted walking; case series; conservative treatment; intermittent claudication; peripheral arterial diseases; walking exercise.
Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
There are no conflicts of interest.
Figures
Similar articles
-
Improving walking ability and ankle brachial pressure indices in symptomatic peripheral vascular disease with intermittent pneumatic foot compression: a prospective controlled study with one-year follow-up.J Vasc Surg. 2000 Apr;31(4):650-61. doi: 10.1067/mva.2000.103969. J Vasc Surg. 2000. PMID: 10753272 Clinical Trial.
-
Exercise With Low-Loads and Concurrent Partial Blood Flow Restriction Combined With Patient Education in Females Suffering From Gluteal Tendinopathy: A Feasibility Study.Front Sports Act Living. 2022 Apr 14;4:881054. doi: 10.3389/fspor.2022.881054. eCollection 2022. Front Sports Act Living. 2022. PMID: 35498515 Free PMC article.
-
Effectiveness of blood flow-restricted slow walking on mobility in severe multiple sclerosis: A pilot randomized trial.Scand J Med Sci Sports. 2020 Oct;30(10):1999-2009. doi: 10.1111/sms.13764. Epub 2020 Jul 25. Scand J Med Sci Sports. 2020. PMID: 32645227 Clinical Trial.
-
Feasibility study to evaluate cycloidal vibration therapy for the symptomatic treatment of intermittent claudication.Pilot Feasibility Stud. 2019 Nov 17;5:133. doi: 10.1186/s40814-019-0514-6. eCollection 2019. Pilot Feasibility Stud. 2019. PMID: 31832228 Free PMC article.
-
The feasibility, safety, and efficacy of upper limb garment-integrated blood flow restriction training in healthy adults.Pilot Feasibility Stud. 2022 Feb 8;8(1):34. doi: 10.1186/s40814-022-00995-4. Pilot Feasibility Stud. 2022. PMID: 35135623 Free PMC article.
Cited by
-
Feasibility of Blood Flow Restriction Exercise in Adults with a Non-surgically Treated Achilles Tendon Rupture; a Case Series.Int J Exerc Sci. 2024 Jan 1;17(3):140-153. doi: 10.70252/QGAF3184. eCollection 2024. Int J Exerc Sci. 2024. PMID: 38665686 Free PMC article.
References
-
- Gerhard-Herman MD, Gornik HL, Barrett C, et al. . 2016 AHA/ACC Guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2017;135:e686–e725. - PMC - PubMed
-
- Song P, Rudan D, Zhu Y, et al. . Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis. Lancet Glob Health 2019;7:e1020–e30. - PubMed
-
- Hamburg NM, Creager MA. Pathophysiology of intermittent claudication in peripheral artery disease. Circ J 2017;81:281–289. - PubMed
LinkOut - more resources
Full Text Sources